NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Price Target Increased to C$5.50 by Analysts at BMO Capital Markets

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its target price hoisted by BMO Capital Markets from C$5.25 to C$5.50 in a research report report published on Thursday, BayStreet.CA reports.

Other equities analysts have also recently issued research reports about the company. National Bankshares set a C$5.50 target price on NorthWest Health Prop Real Est Inv Trust and gave the company a sector perform rating in a research note on Wednesday, September 4th. CIBC cut their price target on NorthWest Health Prop Real Est Inv Trust from C$5.75 to C$5.50 in a report on Thursday, August 15th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of Hold and an average price target of C$5.50.

NorthWest Health Prop Real Est Inv Trust Price Performance

TSE:NWH.UN opened at C$5.23 on Thursday. The business’s 50-day moving average price is C$5.25 and its 200 day moving average price is C$5.05. The firm has a market cap of C$1.29 billion, a P/E ratio of -3.29, a PEG ratio of 0.74 and a beta of 1.05. NorthWest Health Prop Real Est Inv Trust has a 52-week low of C$3.89 and a 52-week high of C$5.88. The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42.

NorthWest Health Prop Real Est Inv Trust Company Profile

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.